Home Renal Dialysis Machine Offers Patients More Freedom
|
By HospiMedica International staff writers Posted on 18 May 2009 |
A new home dialysis machine helps patients with kidney failure and end stage renal disease (ESRD) self-administer peritoneal dialysis at home while they sleep.
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
Latest Critical Care News
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
- Reduced-Intensity Transplant Regimen Expands Donor Access in Sickle Cell Disease
- Battery-Free ECG Patch Enables Continuous Arrhythmia Monitoring
- Spinal Cord Interface Restores Bladder Control in Preclinical Study
- Rapid Clotting Gel Improves Emergency Bleeding Control
Channels
Artificial Intelligence
view channel
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreFacial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes
Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read moreSurgical Techniques
view channel
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







